- Maginative: Figma taps Google’s Gemini for Faster, Enterprise-Ready AI Inside its Design Platform (Oct 9, 2025)
Integrations will enhance image generation and editing within Figma and help with enterprise governance, allowing admins to control AI feature access and data usage for model training. - WSJ: Exclusive | Microsoft Tries to Catch Up in AI With Healthcare Push, Harvard Deal (Oct 8, 2025)
Microsoft aims to become a leading AI chatbot provider, reducing its reliance on OpenAI by focusing on healthcare applications for its Copilot assistant. This update, developed in collaboration with Harvard Medical School, will offer more credible health information, and Microsoft is developing tools to help users find healthcare providers. - Google: Introducing the Gemini 2.5 Computer Use model (Oct 7, 2025)
The new model empowers agents to interact directly with user interfaces for tasks like filling forms and navigating web pages. And the possibilities are immense, but software testing seems like a great candidate for tools like this. - NY Times: What the Arrival of A.I. Video Generators Like Sora Means for Us (Oct 9, 2025)
Sora has become so realistic that it undermines the reliability of video as proof of events. It’s simply difficult to distinguish between real and fake videos. - WSJ Opinion: AI and the Fountain of Youth (Oct 8, 2025)
AI is accelerating drug development, analyzing medical data, and improving diagnostics, potentially leading to longer, healthier lives. “Thanks to AI, the process of identifying and developing new drugs, once a decade long slog, is being compressed into months.” - WSJ Opinion: I’ve Seen How AI ‘Thinks.’ I Wish Everyone Could. (Oct 9, 2025)
Understanding how AI models function, including their training data and mathematical structure, is crucial, especially as AI increasingly impacts human endeavors like writing and art. - WSJ: AI Investors Are Chasing a Big Prize. Here’s What Can Go Wrong. (Oct 5, 2025)
Investing in AI is risky due to the high costs, uncertain timelines, and potential for competition. I’d argue that these risks are present in almost any investment decision.